MONITORING THE CELLULAR COMPONENTS OF THE IMMUNE SYSTEM DURING CLINICAL TRIALS: A TRANSLATIONAL MEDICINE APPROACH - Flow Cytometry in Drug Discovery and Development - page 197

8. Feldmann, M. Translating molecular insights in autoimmunity into effective therapy. Ann.
Rev. Immunol. 2009;27:1-27.
9. Reiner SL, Sallusto F, Lanzavecchia A. Division of labor with a workforce of one:
challenges in specifying effector and memory T cell fate. Science 2007;317(5838):
622-625.
10. Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and
infection. Int. Immunol. 2009;21(5):489-498.
11. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu. Rev. Immunol.
2009;27:485-517.
12. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-
induced arthritis in IL-17-deficient mice. J. Immunol. 2003;171:6173-6177.
13. Sakaguchi S, Powrie F. Reviewed in emerging challenges in regulatory T cell function and
biology. Science 2007;317(5838):627-629.
14. Zikherman J, Weiss A. Antigen receptor signaling in the rheumatic diseases. Arthritis Res.
Ther. 2009;11:202.
15. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune
inflammation. Arthritis Res. Ther. 2005;7 (Suppl. 2): S4-S14.
16. Leipe J, Skapenko A, Lipsky PE, Schulze-Koops H. Regulatory T cells in rheumatoid
arthritis. Arthritis Res. Ther. 2005;7:93-99.
17. Looney RJ, Anolik J, Sanz I. B lymphocytes in systemic lupus erythematosus: lessons from
therapy targeting B cells. Lupus 2004;13:381-390.
18. Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, Hansen A, Burmester
GR, Diamond B, Lipsky PE, Dorner T. Activated memory B cell subsets correlate with
disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD,
and CD95. Arthritis Rheum. 2008;58(6):1762-1773.
19. Enghard P, Riemekasten G. Immunology and the diagnosis of lupus nephritis. Lupus
2009;18:287.
20. Fernandez DR, Telarico T, Bonilla E, Li Q, Banerjee S, Middleton FA, Phillips PE, Crow
MK, Oess S, Muller-Esterl W, Perl A. Activation of mammalian target of rapamycin
controls the loss of TCR z in lupus T cells through HRES-1/Rab4-regulated lysosomal
degradation. J. Immunol. 2009;182:2063-2073.
21. Li Y, Harada T, Juang YT, Kyttaris VC, Wang Y, Zidanic M, Tung K, Tsokos GC.
Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and
migration in patients with systemic lupus erythematosus. J. Immunol. 2007;178:
1938-1947.
22. Crisp ın JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC,
Juang YT, Tsokos GC. Expanded double negative T cells in patients with systemic lupus
erythematosus produce IL-17 and infiltrate the kidneys. J.

Immunol. 2008;181:

8761-8766.
23. Kwok SK, Lee JY, Park SH, Cho ML, Min SY, Park SH, Kim HY, Cho YG. Dysfunctional
interferon- a production by peripheral plasmacytoid dendritic cells upon Toll-like
receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res.
Ther. 2008;10:R29.
24. Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F,
Radbruch A, Burmester GR, Riemekasten G. CXCR3 þ CD4 þ T cells are enriched in